The Management Performance Evaluation Of Biopharmacy Public Companies In Our Country

Biopharmacy industry,as one of the four high technology industries in the 21 century,is rewarded as "the morning sun industry" and "the gold industry" for its great scientific research value,obvious economy yield,high growth speed and wide development perspective. Government,high technology field and enterprise field all pay high attention to it and support it greatly. Our country regards the biopharmacy industry as the emphasis and strategic target of the scientific technology development. Since 1999,many companies in our country started to go into the biopharmacy field by all kinds of forms,and invested the biopharmacy industry during the two years of 1997-1998. A few years passed,what is the performance of the companies which have invested the biopharmacy industry? In this dissertation,I will select the excellent public companies which represent the biopharmacy industry as the study target,use the factor analysis method based on finance measures to evaluate the public companies of the biopharmacy industry. Through the analysis in this dissertation,I hope that it can supply the message and reference for the decider in the biopharmacy industry,the enterprisers who will plan to invest the biopharmacy field,government officers and many investors who care for the public companies of the biopharmacy.This dissertation is composed of 5 chapters. The topic of the first chapter is mainly to introduce the concept and the character of the biopharmacy,the development outline of the biopharmacyindustry in our civil country and outside of our country and the public companies outline of the biopharmacy industry in our country.Chapter two mainly discusses the present evaluation methods of the corporation performance and the way which will be used in this dissertation.Chapter three mainly discusses the concept,model,steps of the factor analysis method and the selection of the evaluation measures,source of the research data.Chapter four is the emphasis of this dissertation,it focuses on the result of the performance evaluation of the biopharmacy public companies. Chapter five mainly discusses the conclusion and the revelation.